AQP4 and schizophrenia: In conclusion, a systematic exploration has been conducted on the intricate role of blood–brain barrier (BBB) dysfunction in schizophrenia, effectively bridging the divide between molecular biomarkers such as aquaporin-4 (AQP4) and advanced neuroimaging techniques like arterial spin labeling (ASL).